Tobechukwu J Okobi

61PUBLICATIONS
409CO-AUTHORS
Radiation therapyMolecular targetsCancer diagnosisCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jul 22, 2026
A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.

|Jun 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|May 30, 2026
Top advances of the year: Radiopharmaceutical therapy for prostate cancer.

|May 11, 2026
Temporal Trends in the Frequency of Concomitant Cancer and Cerebrovascular Disease Diagnoses in the United States.

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 09, 2026
Assessing the patient reported outcomes (PROs) of enfortumab vedotin plus pembrolizumab versus platinum-based chemotherapy in patients with advanced urothelial carcinoma in the EV-302 study.

Tobechukwu J Okobi, Neil Vaishampayan, Deepthi Subramanya

Pageof 11

Frequent Collaborators

11 joint publications

Cora N Sternberg

10 joint publications

Michael Sigouros

10 joint publications

Himisha Beltran

7 joint publications

Olivier Elemento